socaltech.com
Los Angeles-based
Appia Bio, a biotech startup focused on developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, has launched from stealth mode, saying it has raised $52M in a Series A funding round. The funding was led by 8VC, and also included Two Sigma Ventures, Sherpa Healthcare Partners and Freeflow Ventures. The company said its technology was originally developed in the laboratory of Lili Yang, PhD, associate professor at University of California, Los Angeles (UCLA). Appia said that Francisco Gimenez, PhD, and David Moskowitz, PhD, of 8VC, both join the company s board, with David Baltimore, PhD, of the California Institute of Technology (Caltech) serving as Chairman. The company said the proceeds from the funding will go to support advancement of its therapy candidates.
Rollins receives $6 million grant from Gilead’s HIV initiative
Emory’s Rollins School of Public Health has announced a $6 million grant from Gilead Sciences, Inc. over three years to continue to build the capacity of organizations working on the frontlines of the HIV crisis in communities across the Southern United States.
Emory will serve as one of four Gilead COMPASS coordinating centers alongside the Southern AIDS Coalition, the University of Houston Graduate College of Social Work, and Wake Forest School of Divinity to provide direct support to local community organizations to help mitigate the HIV epidemic in the South.
This is part of a second wave of funding from Gilead, manufacturer of antiretroviral therapies for HIV/AIDS. Emory’s COMPASS coordinating center has directly distributed more than $4.3 million to 104 community organizations, and is directed by Neena Smith-Bankhead, director of capacity building and community engagement. More information here.
人孔蓋也能很美？8款絕美設計人孔蓋遍布台北，地圖一次看，尋寶還能了解在地故事｜數位時代 bnext.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnext.com.tw Daily Mail and Mail on Sunday newspapers.